Antimicrobial blue light inactivation of biofilms formed by clinical isolates of multidrug-resistant microorganisms

Raquel Ferrer-Espada; Yanyan Fang; Tianhong Dai

doi:10.1117/12.2288520

8 February 2018 Antimicrobial blue light inactivation of biofilms formed by clinical isolates of multidrug-resistant microorganisms

Raquel Ferrer-Espada, Yanyan Fang, Tianhong Dai

Author Affiliations +

Proceedings Volume 10479, Light-Based Diagnosis and Treatment of Infectious Diseases; 104790N (2018) https://doi.org/10.1117/12.2288520
Event: SPIE BiOS, 2018, San Francisco, California, United States

Abstract

Antibiotic resistance is one of the most serious threats to public health. It is estimated that at least 23,000 people die each year in the USA as a direct result of antibiotic-resistant infections. In addition, many antibiotic-resistant microorganisms develop biofilms, surface-associated microbial communities that are extremely resistant to antibiotics and the immune system. A light-based approach, antimicrobial blue light (aBL), has attracted increasing attention due to its intrinsic antimicrobial effect without the involvement of exogenous photosensitizers. In this study, we investigated the effectiveness of this non-antibiotic approach against biofilms formed by multidrug-resistant (MDR) microorganisms. MDR Acinetobacter baumannii, Escherichia coli, Candida albicans, and Pseudomonas aeruginosa biofilms were grown either in 96-well microtiter plates for 24 h or in a CDC biofilm reactor for 48 h, and then exposed to aBL at 405 nm emitted from a light-emitting diode (LED). We demonstrated that, for the biofilms grown in the CDC biofilm reactor, approximately 1.88 log₁₀ CFU reduction was achieved in A. baumannii, 2.78 log10 CFU in E. coli and 3.18 log₁₀ CFU in P. aeruginosa after 162 J/cm² , 576 J/cm² and 500 J/cm² aBL were delivered, respectively. For the biofilms formed in the 96-well microtiter plates, 5.67 and 2.46 log₁₀ CFU reduction was observed in P. aeruginosa and C. albicans polymicrobial biofilm after an exposure of 216 J/cm² . In conclusion, aBL is potentially an alternative non-antibiotic approach against MDR biofilm-related infections. Future studies are warranted to investigate other important MDR microorganisms, the mechanism of action of aBL, and aBL efficacy in vivo.

Citation Download Citation

Raquel Ferrer-Espada, Yanyan Fang, and Tianhong Dai "Antimicrobial blue light inactivation of biofilms formed by clinical isolates of multidrug-resistant microorganisms", Proc. SPIE 10479, Light-Based Diagnosis and Treatment of Infectious Diseases, 104790N (8 February 2018); https://doi.org/10.1117/12.2288520

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available

Members: $17.00

Non-members: $21.00 ADD TO CART

PROCEEDINGS
8 PAGES

DOWNLOAD PAPER SAVE TO MY LIBRARY

GET CITATION

RIGHTS & PERMISSIONS

Get copyright permission Get copyright permission on Copyright Marketplace

KEYWORDS

Microorganisms

Confocal microscopy

Pathogens

Resistance

Bacteria

Fungi

Light emitting diodes

Show All Keywords

Keywords/Phrases

Search In:

Publication Years